HK1161289A1 - 雞敗血支原體製劑 - Google Patents
雞敗血支原體製劑Info
- Publication number
- HK1161289A1 HK1161289A1 HK12101445.5A HK12101445A HK1161289A1 HK 1161289 A1 HK1161289 A1 HK 1161289A1 HK 12101445 A HK12101445 A HK 12101445A HK 1161289 A1 HK1161289 A1 HK 1161289A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- mycoplasma gallisepticum
- formulation
- gallisepticum formulation
- mycoplasma
- gallisepticum
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
- C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/35—Mycoplasma
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/87—Mycoplasma
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14647209P | 2009-01-22 | 2009-01-22 | |
PCT/US2010/021749 WO2010085611A2 (en) | 2009-01-22 | 2010-01-22 | Mycoplasma gallisepticum formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1161289A1 true HK1161289A1 (zh) | 2012-08-24 |
Family
ID=42356391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12101445.5A HK1161289A1 (zh) | 2009-01-22 | 2012-02-14 | 雞敗血支原體製劑 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8668912B2 (zh) |
EP (1) | EP2389433B1 (zh) |
JP (1) | JP5642710B2 (zh) |
KR (1) | KR101715159B1 (zh) |
CN (1) | CN102292432B (zh) |
BR (1) | BRPI1006947B1 (zh) |
CA (1) | CA2749213C (zh) |
HK (1) | HK1161289A1 (zh) |
MX (1) | MX2011007732A (zh) |
WO (1) | WO2010085611A2 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2943219B1 (en) * | 2012-09-10 | 2021-12-15 | Szathmary, Dr. Susan | Vaccine to prevent mycoplasmal infection in waterfowl |
CN106967829A (zh) * | 2017-05-18 | 2017-07-21 | 隋兆峰 | 一种鉴别mg 6/85株的套式pcr检测方法 |
CN110218808B (zh) * | 2019-06-28 | 2021-07-13 | 华中农业大学 | 滑液囊支原体和鸡毒支原体的四重pcr检测试剂盒 |
AU2023249151A1 (en) * | 2022-04-06 | 2024-09-19 | University Of Georgia Research Foundation, Inc. | Live mycoplasma gallisepticum vaccines |
WO2024118234A2 (en) * | 2022-07-20 | 2024-06-06 | University Of Connecticut | Rationally designed mycoplasma gallisepticum subunit vaccine |
CN118078972A (zh) * | 2024-03-07 | 2024-05-28 | 佛山科学技术学院 | 一种鹅源鸡毒支原体灭活疫苗及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5196514A (en) * | 1990-03-06 | 1993-03-23 | The University Of Georgia Research Foundation, Inc. | Method of detecting mycoplasma infection in poultry and compositions therefor |
WO1993001276A1 (en) | 1991-07-12 | 1993-01-21 | Smithkline Beecham Corporation | Continuous cell line and vaccine against avian coccidia |
US7217420B2 (en) * | 2002-07-13 | 2007-05-15 | The University Of Georgia Research Foundation, Inc. | Mycoplasma gallisepticum formulation |
WO2004020980A2 (en) * | 2002-08-27 | 2004-03-11 | University Of Georgia Research Foundation, Inc. | Assays for the detection of biliverdin in birds and reptiles |
CN101365484A (zh) | 2005-08-15 | 2009-02-11 | 瓦克辛公司 | 通过给药非复制型载体化疫苗而进行的对禽类的免疫 |
-
2010
- 2010-01-22 BR BRPI1006947A patent/BRPI1006947B1/pt active IP Right Grant
- 2010-01-22 JP JP2011548121A patent/JP5642710B2/ja active Active
- 2010-01-22 EP EP10733876.6A patent/EP2389433B1/en active Active
- 2010-01-22 KR KR1020117019444A patent/KR101715159B1/ko active IP Right Grant
- 2010-01-22 CA CA2749213A patent/CA2749213C/en active Active
- 2010-01-22 CN CN2010800052398A patent/CN102292432B/zh active Active
- 2010-01-22 US US13/140,929 patent/US8668912B2/en active Active
- 2010-01-22 WO PCT/US2010/021749 patent/WO2010085611A2/en active Application Filing
- 2010-01-22 MX MX2011007732A patent/MX2011007732A/es active IP Right Grant
-
2012
- 2012-02-14 HK HK12101445.5A patent/HK1161289A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP2389433A4 (en) | 2012-10-17 |
MX2011007732A (es) | 2011-11-04 |
KR20110123748A (ko) | 2011-11-15 |
KR101715159B1 (ko) | 2017-03-10 |
JP2012515552A (ja) | 2012-07-12 |
BRPI1006947A2 (pt) | 2016-10-04 |
US20120021005A1 (en) | 2012-01-26 |
BRPI1006947B1 (pt) | 2020-02-04 |
CA2749213C (en) | 2017-08-15 |
EP2389433B1 (en) | 2015-11-25 |
CN102292432B (zh) | 2013-05-22 |
US8668912B2 (en) | 2014-03-11 |
CN102292432A (zh) | 2011-12-21 |
WO2010085611A3 (en) | 2010-11-25 |
WO2010085611A2 (en) | 2010-07-29 |
CA2749213A1 (en) | 2010-07-29 |
JP5642710B2 (ja) | 2014-12-17 |
EP2389433A2 (en) | 2011-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL290077A (en) | Improved lipid formulation | |
IL214615A0 (en) | Anti-fungal formulation | |
GB0912239D0 (en) | Cosmetic formulation | |
GB0907003D0 (en) | Formulation | |
ZA201001740B (en) | Attenuated mycoplasma gallisepticum strains | |
GB201020601D0 (en) | Topical formulation | |
HK1161289A1 (zh) | 雞敗血支原體製劑 | |
GB0822633D0 (en) | Formulation | |
EP2413905A4 (en) | COMPOSITION | |
ZA201004772B (en) | Novel formulation | |
PT2428538T (pt) | Formulação com propriedades de isolamento | |
GB0814376D0 (en) | Formulation | |
GB2484412B (en) | Titrator | |
GB0911213D0 (en) | Formulation | |
GB201006326D0 (en) | Formulation | |
GB0902472D0 (en) | Formulation | |
GB0906291D0 (en) | Formulation | |
GB0907410D0 (en) | Formulation | |
GB0915672D0 (en) | Curable formulation | |
GB0915674D0 (en) | Cationically curable formulation | |
GB201005992D0 (en) | Formulation | |
GB201001978D0 (en) | Formulation | |
GB201002000D0 (en) | Formulation | |
PL393180A1 (pl) | Preparat weterynaryjny | |
PL390421A1 (pl) | Preparat weterynaryjny |